NextCure, Inc. - Common Stock — Quarterly Cash Flow (NASDAQ:NXTC) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Total assets 67.14 M47.69 M39.61 M50.18 M37.98 M Total liabilities 11.28 M16.04 M15.97 M15.24 M11.26 M Total equity 55.85 M29.65 M23.65 M34.94 M26.72 M Total liabilities & shareholders' equities 67.14 M47.69 M39.61 M50.18 M37.98 M Total debt ————— Net debt —————

News

3 Cancer Stocks to Watch as Oncology Innovation Accelerates

NextCure, Inc. (NXTC) Discusses Preliminary Phase I Data for SIM0505 in Platinum-Resistant Ovarian Cancer and Uterine Serous Carcinoma - Slideshow (NASDAQ:NXTC) 2026-06-02

NextCure provides updates on ADC programs, reports cash position

NextCure secures $21.5 million in private placement to extend cash runway

NextCure raises $21.5 million in private placement to fund ADC programs

Does NextCure (NXTC) Have the Potential to Rally 107.88% as Wall Street Analysts Expect?

Curanex Pharmaceuticals closes $15 million IPO on NASDAQ

NextCure (NXTC) Q2 Loss Widens 71%

NextCure stock soars after positive data for bone disease treatment

Why Deckers Outdoor Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket - Absci (NASDAQ:ABSI), AST SpaceMobile (NASDAQ:ASTS)

Piper Sandler lowers NextCure stock price target to $15 after reverse split

NextCure initiates one-for-twelve reverse stock split on Nasdaq